Murdo is a Director and a member of the Healthcare sector team. He joined Bridgepoint in 2016.

He has worked on a number of transactions, including Pharmazell and Novasep (now Axplora), Vermaat, Nuvias, and MyDentist. He has also been involved in portfolio management and sat on the boards of WiggleCRC, Care UK and MiQ.

Prior to joining Bridgepoint Murdo worked at L.E.K. Consulting in London and Boston, advising on PE due-diligence and corporate strategy projects, primarily in Healthcare and Services. Raised in Scotland, Murdo is based in London, and holds a degree in History and Politics from the University of Oxford.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.